Sortilin staining intensity in grade 1–2 glioma was observed to be low in all cases (Figure 2A,B and Table 2), and ten out of twelve cases of grade 3 were observed to have low-intensity staining for sortilin (Figure 2C and Table 2). This evidence concerns the gene SORT1 and central nervous system cancer.